Early Detection of GEnetic Risk (EDGE)

NACompletedINTERVENTIONAL
Enrollment

20,184

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

May 31, 2023

Study Completion Date

June 1, 2023

Conditions
Genetic Predisposition
Interventions
BEHAVIORAL

Population-level screening

"The study intervention involves having patients complete a familial cancer risk assessment survey. Those who are found to be at high risk will be offered genetic testing for a panel of hereditary cancers. A previvor plan will be created to assist patients and their providers in completing the appropriate follow-up for those with a mutation identified."

Trial Locations (2)

59101

Billings Clinic, Billings

98405

MultiCare Health System, Tacoma

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT04746794 - Early Detection of GEnetic Risk (EDGE) | Biotech Hunter | Biotech Hunter